Christiana Care Health System is one of the largest health care providers in the mid-Atlantic, serving all of Delaware and parts of PA, MD and NJ.

ChristianaCare

New Row

Contact expert @[Full Name](fullname), @[Job Title](job_title) at @[Organization](organization) for media, speaking, professional opportunities and more.

@[Full Name](fullname) at @[Organization](organization) | Contact Form

Expert Inquiry

Open Sans

Consensus statement and clinical pathway for the management of colon cancer with peritoneal metastases in the state of Delaware

Adjuvant Chemoradiotherapy in Resected Pancreatic Ductal Adenocarcinoma: Where Does the Benefit Lie? A Nomogram for Risk Stratification and Patient Selection

Adrenal biopsy, as a diagnostic method, is associated with decreased overall survival in patients with T1/T2 adrenocortical carcinoma: A propensity score-matched analysis

Surgical Management of the Axilla of HER2+ Breast Cancer in the Z1071 Era: A Propensity-Score-Matched Analysis of the NCDB

Patient Risk Subgroups Predict Benefit of Adjuvant Chemotherapy in Stage II Rectal Cancer Patients Following Neoadjuvant Chemoradiation and Total Mesorectal Excision

Arvind Sabesan, M.D., FACS, is a double board-certified Surgical Oncologist at ChristianaCare's Helen F. Graham Cancer Center & Research Institute.

He specializes in the treatment of patients with complex oncologic malignancies using minimally invasive techniques. He is extensively trained in advanced and innovative modalities to diagnose, stage, and treat patients with advanced cancers.

He employs a variety of strategies, including minimally invasive techniques (robotic surgery) and multidisciplinary cancer care to personalize treatment for patients with a wide range of oncologic disorders.

Select Inquiry Type